Stephens & Co. Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsDowngradesPrice Target
Stephens & Co. analyst Steven Etoch downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $68 to $73.
Stephens & Co. analyst Steven Etoch downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $68 to $73.